News & Updates

Atopic dermatitis (AD) does not seem to induce an increase in the risk of venous thromboembolism (VTE) when considering underlying risk factors, suggests a study. Moreover, patients with AD show a lower VTE risk than those with rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA), or ankylosing spondylitis (AS).

Progressive resistant training (PRT) does not seem to work better than neuromuscular exercise (NEMEX) for easing hip pain and improving functional performance or hip-related quality of life (QoL) in patients with hip osteoarthritis (OA), reports a recent study.

Researchers in a cross-disciplinary team from the Chinese University of Hong Kong (CUHK) have developed retrievable nanorobots anchored with tissue plasminogen activator (tPA-nbots) that increase thrombolysis rates by 20 times with a 42-fold lower tPA dose than pure tPA treatment. With a catheter-assisted magnetic navigation system, the tPA-nbots recanalized distal and small vessel branches, showing potential in reducing brain damage and treatment side effects among patients with ischaemic stroke.

Patients with gynaecologic cancer who used apixaban for postoperative venous thromboembolism (VTE) prophylaxis achieve similar 90-day and lower 30-day rates of VTE when compared with those who used enoxaparin, reports a study presented at SGO 2024.